TB
Treeline Biosciences, Inc.
SEC filingBiotechnology · Watertown, MA
Amount raised$200.1Msold at filing
Total offering$250M$49.9M still open
Investors in the raise22count reported to the SEC
FiledSep 4, 2025first sale Aug 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steven H. ElmsDirector
Kristina H. BurowDirector
David H. BonitaDirector
Joshua H. BilenkerExecutive Officer, Director, Promoter
Jeffrey H. EngelmanExecutive Officer, Director, Promoter
Aftab H. KheraniDirector
Ali H. SatvatDirector
Avi H. NaiderDirector
David H. SchenkeinDirector
Executive officers, directors and promoters as listed on the Form D.